XML 24 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities:    
Net income (loss) $ 4,895,137 $ 20,216,876
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Change in unrealized (gain) loss on open commodity futures contracts (2,813,280) (3,351,170)
(Increase) decrease in dividends receivable 133,414 115,330
(Increase) decrease in interest receivable (611) (93,975)
(Increase) decrease in prepaid insurance (25,532) (16,491)
Increase (decrease) in General Partner management fees payable (19,034) (5,011)
Increase (decrease) in professional fees payable (40,260) (70,698)
Increase (decrease) in directors' fees payable (706) 45
Net cash provided by (used in) operating activities 2,129,128 16,794,906
Cash Flows from Financing Activities:    
Addition of partnership shares 42,501,027 8,311,953
Redemption of partnership shares (63,863,294) (24,392,760)
Net cash provided by (used in) financing activities (21,362,267) (16,080,807)
Net Increase (Decrease) in Cash and Cash Equivalents (19,233,139) 714,099
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 111,818,839 130,936,411
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 92,585,700 131,650,510
Components of Cash, Cash Equivalents and Equity in Trading Accounts:    
Cash and cash equivalents 61,937,071 93,380,409
Equity in Trading Accounts:    
Cash and cash equivalents 30,648,629 38,270,101
Total Cash, Cash Equivalents and Equity in Trading Accounts $ 92,585,700 $ 131,650,510